FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is intended to inhibit and / or prevent the growth of microbio films. Antimicrobial agent contains lactoferrin, pharmaceutically acceptable additives and mono[(2-dimethylamino)ethyl]carboxylic esters of the general formula R-O-(Et)-N(Me)2, where R is a carboxylic acid selected from the range: fumaric, succinic, maleic, α-ketoglutar, oxalic, D, L-malic, pyruvic, Et - ethyl and Me - methyl. Ratio (wt.) Lactoferrin / esters of carboxylic acids is from 1/1 to 1/3.
EFFECT: use of the invention allows to increase the antiseptic properties against the vast majority of gram-positive and gram-negative bacteria, fungicidal properties against fungi, and also provides effective prevention and treatment of conditions of the mucous membranes and dental diseases.
1 cl, 16 tbl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MOUTH CAVITY RINSING AGENT | 2006 |
|
RU2312657C2 |
| COMPOSITIONS AND MEANS OF CLEANING | 2009 |
|
RU2441641C1 |
| ANTIMICROBIAL COMPOSITIONS | 2013 |
|
RU2694758C2 |
| COMPOSITION OF ACTIVE DENTAL BASE FOR ORAL CARE PRODUCTS, STIMULATING RESTORATIVE AND REPARATIVE PROCESSES IN ORAL CAVITY TISSUES, AND COMPOSITION FOR ORAL HYGIENE BASED THEREON (VERSIONS) | 2023 |
|
RU2822421C1 |
| COMPOSITIONS FOR ORAL CAVITY CARE CONTAINIG QUATERNARY AMMONIUM ANTIBACTERIAL REAGENTS WITH INCREASED LEVELS OF BIOLOGICAL AVAILABILITY | 2005 |
|
RU2325899C2 |
| PHYTOCOMPOSITION FOR ORAL CARE | 2016 |
|
RU2635509C1 |
| MOUTH RINSE EMULSIONS | 2013 |
|
RU2648461C2 |
| INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
| ORAL CARE PRODUCT AND METHODS FOR USING AND PREPARING SAME | 2010 |
|
RU2597159C2 |
| LACTOFERRIN BASED BABY POWDER | 2020 |
|
RU2743558C1 |
